![David William Ball](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David William Ball
Director/Board Member at
ALLERGY THERAPEUTICS PLC
Profile
David William Dawson Ball is currently an Independent Non-Executive Director at Allergy Therapeutics Plc.
He is also a Director at Argonaute RNA Ltd. and Deepform Ltd. Previously, he served as a Director at Brainomix Ltd. Mr. Ball completed his undergraduate and graduate degrees at the University of Cambridge.
David William Ball active positions
| Companies | Position | Start |
|---|---|---|
| ALLERGY THERAPEUTICS PLC | Director/Board Member | 2024-06-26 |
Argonaute RNA Ltd.
 Argonaute RNA Ltd. Miscellaneous Commercial ServicesCommercial Services Develops safe and reliable methods of temporarily silencing target genes in different tissue cells | Director/Board Member | - |
Former positions of David William Ball
| Companies | Position | End |
|---|---|---|
Brainomix Ltd.
 Brainomix Ltd. BiotechnologyHealth Technology Develops a software for medical analysis | Director/Board Member | - |
Training of David William Ball
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
4
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Allergy Therapeutics Plc
 Allergy Therapeutics Plc Pharmaceuticals: OtherHealth Technology Manufactures subcutaneous and sublingual immunotherapy treatments for a wide range of allergic conditions | Health Technology |
Brainomix Ltd.
Brainomix Ltd. BiotechnologyHealth Technology Develops a software for medical analysis | Health Technology |
Argonaute RNA Ltd.
Argonaute RNA Ltd. Miscellaneous Commercial ServicesCommercial Services Develops safe and reliable methods of temporarily silencing target genes in different tissue cells | Commercial Services |
- Stock Market
- Insiders
- David William Ball
